- Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
- Facing pharmacy trends for the remainder of the year
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
- Cardinal Health’s Independence Medical unit helps pharmacy owners tap into growing home healthcare market
BRISTOL, Tenn. — Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.
The two drug makers announced Tuesday the submission for Acurox (oxycodone hydrochloride), an immediate-release tablet for relief of moderate to severe pain.
The tablets use Acura’s aversion technology, designed to deter abuse of the drug by dissolving or crushing the pills.